M. Maierredelsperger et al., FETAL HEMOGLOBIN AND F-CELL RESPONSES TO LONG-TERM HYDROXYUREA TREATMENT IN YOUNG SICKLE-CELL PATIENTS, Blood, 91(12), 1998, pp. 4472-4479
We have studied the cellular and molecular responses to long-term hydr
oxyurea (HU) treatment in 29 severely affected young patients with sic
kle cell disease (mean age, 10.9 +/- 4.1 years). Patients received HU
at 20 mg/kg/d on 4 consecutive days per week initially, with a monthly
escalated dose avoiding marrow-toxicity (mean steady-state dose, 34.2
+/- 4.6 mg/kg/d) for 12 to 36 months (mean duration, 22 months). The
studied parameters were hemoglobin F (HbF), F reticulocytes (F retics)
, F cells, the amount of HbF per F cell (F/F cell), polymer tendency a
t 40% and 70% oxygen saturation, and hemolysis. Initial HbF (Fi) was d
ispersed (from 0.85% to 13.9%). HbF increased in all patients but 1. H
bF at maximal response (Fmax) reached a sustained level varying from a
1.5-fold to a 16-fold Pi after a variable delay (6 to 24 months). Fma
x was not related to HU dosage, but Delta F (Fmax-Fi) was strongly cor
related to Delta MCV (MCVmax-MCVi). HbF increase resulted from the inc
rease of both F cells and F/F cell. In this rather short series, Fi an
d Fmax were not significantly associated with age, gender, or P-globin
haplotype. Neither Fmax nor Delta F was related to bone marrow reserv
e, as measured by baseline reticulocyte or neutrophil counts. However,
Fmax was highly dependent on Pi. When patients are individualized int
o three groups according to Fmax (group 1, Fmax >20% [12 patients]; gr
oup 2, 10% < Fmax < 20% [11 patients]; group 3, Fmax <10% [5 patients]
), Pi is significantly different between groups, being the highest in
group 1. In addition, the best responders (group 1) were significantly
different from patients in the two other groups with higher levels of
total hemoglobin, decreased bilirubin, and decreased polymer tendency
. (C) 1998 by The American Society of Hematology.